Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
2008 for prevention of acute CINV alone
and selective pan-PIM kinase inhibitor
off-target activity) of AMG 925 is about 50-fold as evaluated by comparison of its growth-inhibiting activity in RB-positive (RB+) and RB-negative (RB-) non- acute myeloid leukemia (AML) cancer cell lines
3-d]pyrimidin-4-amine
this agent binds weakly to the vinca-binding site
Bay 55-9837 TFA EG1-OTs 2008 for prevention of acuteBay 55 9837 TFA is a potent and highly selective agonist of VPAC2, with a Kd of 0. 65 nM. Bay 55 9837 TFA may be a useful therapy for the research of type 2 diabetes. Product information Molecular Weight: 3856. 27 Formula: C169H271F3N52O48 Chemical Name: 3 [(1 {[1 ({1 [(1 {[1 ({1 [(5 amino 1 {[1 ({1 [(1 {[1 ({5 amino 1 [(5 amino 1 {[1 ({1 [(1 {[1 ({1 [(5 amino 1 {[1 ({5 amino 1 [(4 carbamimidamido 1 {[1 carbamoyl 2 (4